Virtual Trials Take Centre Stage During Covid-19
Our CEO, Bruce Hellman, answers the below questions and talks to pharmaphorum on how virtual trials are evolving and why they are more important than ever in the midst of the Covid-19 pandemic.
There are myriad approaches to virtual trials at the moment – what technologies are appearing to be the most useful?
What are some best practice tips for running a virtual trial arm?
How is the Covid-19 pandemic changing approaches to virtual trials?
Do you think the pandemic is likely to cause a permanent shift towards more virtual/hybrid trials?
Do you foresee a time when virtual trials will be the most common form of study or will hybrid studies, or even RCTs, dominate?
Read the full article.